Open AccessAbstract 1952: Epigenetic modifiers outperform chemotherapy in prolonging survival in patient-derived xenograft models of Down syndrome AML
Author(s) -
Sonali P. Barwe,
E.A. Kolb,
Anilkumar Gopalakrishnapillai
Publication year - 2017
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2017-1952
Subject(s) - panobinostat , azacitidine , cancer research , epigenetics , cytarabine , medicine , nijmegen breakage syndrome , myeloid , nonsense mutation , haematopoiesis , biology , histone deacetylase inhibitor , myeloid leukemia , mutation , histone deacetylase , dna methylation , stem cell , genetics , histone , gene , dna damage , gene expression , dna , missense mutation , ataxia telangiectasia